SEC Form 3 · accession 0001213900-26-095381
Turbogen Ltd. · TRBG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Neta Zruya Hashai
Officer — Chief Financial Officer
Period of report
Aug 28, 2026
Accepted (ET)
Aug 31, 2026 · 8:11 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0002088375
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary sharesF1 | holding | — | — | — | 176,875 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share option (right to buy)F3,F2 | $5.54 | holding | — | — | — | May 2, 2025 | Oct 5, 2035 | Ordinary shares | 150,000 | — | D |
| Share option (right to buy)F5,F4 | $6.18 | holding | — | — | — | Apr 29, 2027 | Apr 29, 2036 | Ordinary shares | 85,000 | — | D |
Explanation of responses
- F1Represents (i) 21,875 ordinary shares; (ii) 70,000 restricted share units ("RSUs") granted on October 5, 2025, 31.25% of which vest on and the remaining 68.75% vest in equal quarterly installments of 6.25% thereafter, of which 21,875 RSUs have vested and 48,125 remain unvested as of August 25, 2026; and (iii) 85,000 RSUs granted on April 29, 2026, which vest in equal quarterly installments of 6.25% thereafter, of which 85,000 RSUs remain unvested as of August 25, 2026. Each RSU represents the right to receive one ordinary share.
- F2A total of 150,000 options were granted on October 5, 2025 and vested in equal quarterly installments of 6.25% beginning May 2, 2025. As of August 25, 2026, 46,875 options are fully vested and none have been exercised into ordinary shares.
- F3The options were granted with an exercise price of NIS 16.60 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 2.774 to USD $1.00 as of August 24, 2026, resulting in an exercise price of $5.54 per share.
- F4A total of 85,000 options were granted on April 29, 2026 and vested in equal quarterly installments of 6.25% beginning April 29, 2027. As of August 25, 2026, none of options are fully vested and none have been exercised into ordinary shares.
- F5The options were granted with an exercise price of NIS 18.5 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 2.994 to USD $1.00 as of August 24, 2026, resulting in an exercise price of $6.18 per share.